Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump.
about
Continuous glucose monitoring: evidence and consensus statement for clinical useAbstracts from ATTD 20147th International Conference on AdvancedTechnologies & Treatments for DiabetesVienna, Austria, February 5–8, 2014Hypoglycemia early alarm systems based on recursive autoregressive partial least squares models.Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapyContinuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase.Putting brakes on insulin pump infusion to prevent hypoglycemia.The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia.Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home StudyPredictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery.Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.Assessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: drawbacks and way forward.Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm.The role of continuous glucose monitoring in the care of children with type 1 diabetes.Gene therapy for type 1 diabetes moves a step closer to realityOutpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemiaHypoglycemia Early Alarm Systems Based On Multivariable ModelsHypoglycemia Detection and Carbohydrate Suggestion in an Artificial Pancreas.ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemiaSafety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose.Hypo- and Hyperglycemic Alarms: Devices and Algorithms.Automated insulin pump suspension for hypoglycaemia mitigation: development, implementation and implications.Multivariable Adaptive Artificial Pancreas System in Type 1 Diabetes.Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.Effectiveness of Automated Insulin Management Features of the MiniMed® 640G Sensor-Augmented Insulin Pump.Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps.Challenges and Recent Progress in the Development of a Closed-loop Artificial Pancreas.Improved outcomes from diabetes monitoring: the benefits of better adherence, therapy adjustments, patient education, and telemedicine supportEffectiveness of the low-glucose suspend feature of insulin pump during fasting during Ramadan in type 1 diabetes mellitus.Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.The Pathobiology of Diabetes Mellitus
P2860
Q27022628-BEDDD297-4BB6-49F8-B42C-C779BABDE261Q28659224-BFB08AF1-2A9F-4E57-90AE-AAF035C393D3Q30415520-F509DBD0-291D-43F5-92B0-509AC34A2B7AQ30452860-7ADA90E4-EAD2-4CD6-BCC4-E911240F747AQ33786175-B9A451DF-25E6-4A58-B604-5C41F4117FACQ35408311-AC64C9EC-3340-4EE2-9C6A-98A1C3A7D0E8Q35529626-461A85B3-E4CA-4FD6-A5F3-AA3ED637B619Q35684962-710AF1B7-47A3-420D-AD8C-507AD7DC0AB4Q35927924-4D7CA31F-1E7A-48D7-9D5B-4FC089A20A8FQ36340544-39AADA2D-F42E-461D-B9B2-8619A2305146Q36352480-01409A83-D08A-4C82-9CDC-10F94A11EC44Q36520578-7D9ABCB7-4603-4DA2-9DB0-9218000C99AFQ36605727-EB65F2EF-FB21-431C-9041-B5BA96CC8931Q36777662-33140443-BED8-490F-92F8-307DC06F0F58Q36796148-A98368F1-3CE4-4878-8230-2DD067FD0941Q37102080-60CDF7E2-3B99-489A-A431-1FAD41B93DABQ37265218-3FF15FBA-6606-4223-A502-604A327C2D5CQ37391416-9EA9478D-FF14-4009-AB13-60391BFC5AE4Q37429190-8D6920B2-51E8-4776-852B-73D239CB85CAQ37597019-E7927EE8-6B7D-4E75-85B9-24BF3DEFC3D0Q38452793-D2AB1CF3-B641-442D-9470-8EFEB9A60DA5Q38548147-B99BCB57-1E7D-47F4-8869-8401298D18D5Q38622678-F2949B8E-18BC-4EC5-8136-656562C640A6Q39164012-481AFF72-0E31-4A3D-8E56-B3CA3091638FQ39347625-DB9630CC-0FA3-442E-B928-4780A6E36F7BQ39659435-82FC96E3-1B30-410D-A61A-A9286ECA9E52Q41458753-C3692924-2056-4554-9922-35144AD64A23Q42324880-EB4EA30C-93A3-4D10-8EBB-D88B816BD602Q46210251-96F5A939-A5FF-4CF2-80B9-5E69FABB1394Q53280517-9F9A7EB7-3A16-45A8-A770-4A6B6A0E5ADAQ58316252-C1528A63-7951-40A1-9FC5-4142D8678631
P2860
Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Usage and effectiveness of the ...... nic Paradigm Veo insulin pump.
@ast
Usage and effectiveness of the ...... nic Paradigm Veo insulin pump.
@en
type
label
Usage and effectiveness of the ...... nic Paradigm Veo insulin pump.
@ast
Usage and effectiveness of the ...... nic Paradigm Veo insulin pump.
@en
prefLabel
Usage and effectiveness of the ...... nic Paradigm Veo insulin pump.
@ast
Usage and effectiveness of the ...... nic Paradigm Veo insulin pump.
@en
P2093
P2860
P1476
Usage and effectiveness of the ...... nic Paradigm Veo insulin pump.
@en
P2093
Brian Kannard
Francine R Kaufman
John B Welsh
Pratik Agrawal
Qingqing Yang
Sina Askari
P2860
P304
P356
10.1177/193229681100500514
P577
2011-09-01T00:00:00Z